MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-12-2026
American Well Corporation DPO Ratio 2011-2026 | AMWL
Annual DPO Ratio American Well Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.4 | 11.6 | 13.4 | 22.1 | 22.1 | 6.75 | 29.7 | 26.3 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 29.7 | 6.75 | 17.8 |
Quarterly DPO Ratio American Well Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16.5 | 14.9 | 16.5 | - | 16.7 | 14.7 | 12.8 | 10.5 | 13.8 | 16.8 | - | 6.79 | 9.37 | 24.4 | - | 13.6 | 16.1 | 16.1 | - | 12.6 | 12.1 | 17 | - | 15.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 24.4 | 6.79 | 14.6 |
DPO Ratio of other stocks in the Health information services industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
14.4 | - | 0.29 % | $ 206 M |  USA |
 |
Teladoc Health
TDOC
|
19.2 | $ 5.52 | -0.9 % | $ 973 M | USA |
 |
Cerner Corporation
CERN
|
103 | - | - | $ 27.9 B | USA |
 |
Computer Programs and Systems
CPSI
|
17.8 | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
41.9 | - | - | $ 2.94 B | USA |
 |
Castlight Health, Inc.
CSLT
|
36.1 | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
11.7 | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
115 | - | - | $ 6.37 B | USA |
 |
iCAD
ICAD
|
112 | - | - | $ 102 M | USA |
 |
Schrödinger
SDGR
|
35.6 | $ 11.57 | 1.49 % | $ 850 M | USA |
 |
SCWorx Corp.
WORX
|
43.2 | $ 0.13 | 2.95 % | $ 190 K | USA |
 |
Evolent Health
EVH
|
27 | $ 2.38 | 4.85 % | $ 223 M | USA |
 |
NextGen Healthcare
NXGN
|
14.5 | - | - | $ 1.6 B | USA |
 |
1Life Healthcare
ONEM
|
18 | - | - | $ 3.37 B | USA |
 |
10x Genomics
TXG
|
32.5 | $ 20.43 | -2.3 % | $ 2.39 B | USA |
 |
Zhongchao
ZCMD
|
32 | $ 1.78 | -1.11 % | $ 9.27 M |  China |
 |
MTBC
MTBC
|
36.4 | - | -0.58 % | $ 51.7 M | USA |
 |
Premier
PINC
|
28.6 | - | - | $ 2.33 B | USA |
 |
GoodRx Holdings
GDRX
|
191 | $ 2.04 | -0.97 % | $ 787 M | USA |
 |
Signify Health
SGFY
|
57.5 | - | -0.02 % | $ 7.21 B | USA |
 |
R1 RCM
RCM
|
5.63 | - | - | $ 3.81 B | USA |
 |
HealthStream
HSTM
|
26.3 | $ 21.25 | 0.09 % | $ 646 M | USA |
 |
Akerna Corp.
KERN
|
89.4 | - | - | $ 161 M | USA |
 |
Streamline Health Solutions
STRM
|
62 | - | - | $ 21.4 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
10.9 | - | -10.39 % | $ 886 M | USA |
 |
Omnicell
OMCL
|
27.6 | $ 35.2 | 0.74 % | $ 1.62 B | USA |
 |
OptimizeRx Corporation
OPRX
|
24.1 | $ 6.96 | -3.06 % | $ 119 M | USA |
 |
Health Catalyst
HCAT
|
23.8 | $ 1.1 | - | $ 76.9 M | USA |
 |
Phreesia
PHR
|
57.8 | $ 11.65 | 3.28 % | $ 636 M | USA |
 |
NantHealth
NH
|
86.1 | - | -46.64 % | $ 10.4 M | USA |
 |
HealthEquity
HQY
|
12.1 | $ 83.85 | 1.67 % | $ 7.22 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
22.2 | - | - | $ 255 M | USA |
 |
Progyny
PGNY
|
171 | $ 17.79 | 0.23 % | $ 1.53 B | USA |
 |
Veeva Systems
VEEV
|
15.9 | $ 178.28 | 0.1 % | $ 29.2 B | USA |